Cargando…

Calcineurin Inhibitors in the Treatment of Adult Autoimmune Hepatitis: A Systematic Review

BACKGROUND AND AIMS: A considerable number of autoimmune hepatitis (AIH) patients completely or partially fail on first-line treatment. Several studies on the use of calcineurin inhibitors (CNIs) in the treatment of AIH have been published without focusing on indication. The aim was to assess the ef...

Descripción completa

Detalles Bibliográficos
Autores principales:	Baven-Pronk, Martine AMC, Hew, Joffre M., Biewenga, Maaike, Tushuizen, Maarten E., van den Berg, Aad P., Bouma, Gerd, Brouwer, Johannes T., van Hoek, Bart
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	XIA & HE Publishing Inc. 2022
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9634779/ https://www.ncbi.nlm.nih.gov/pubmed/36381101 http://dx.doi.org/10.14218/JCTH.2021.00535

Ejemplares similares

Role of age in presentation, response to therapy and outcome of autoimmune hepatitis
por: Baven-Pronk, Martine A. M. C., et al.
Publicado: (2018)

Early Predictors of Short‐Term Prognosis in Acute and Acute Severe Autoimmune Hepatitis
por: Biewenga, Maaike, et al.
Publicado: (2020)

Development and validation of a prognostic score for long‐term transplant‐free survival in autoimmune hepatitis type 1
por: Biewenga, Maaike, et al.
Publicado: (2021)

Assessing the efficacy and safety of mycophenolate mofetil versus azathioprine in patients with autoimmune hepatitis (CAMARO trial): study protocol for a randomised controlled trial
por: Snijders, Romée J. A. L. M., et al.
Publicado: (2022)

B-cell activating factor and IL-21 levels predict treatment response in autoimmune hepatitis
por: Biewenga, Maaike, et al.
Publicado: (2022)

Antibodies against multiple post-translationally modified proteins aid in diagnosis of autoimmune hepatitis and associate with complete biochemical response to treatment
por: van den Beukel, Michelle D., et al.
Publicado: (2023)

Commentary: Commentary: Antibodies against multiple post-translationally modified proteins aid in diagnosis of autoimmune hepatitis and associate with complete biochemical response to treatment
por: van den Beukel, Michelle D., et al.
Publicado: (2023)

Adverse events related to low dose corticosteroids in autoimmune hepatitis
por: van den Brand, Floris F., et al.
Publicado: (2019)

Biochemical efficacy of tioguanine in autoimmune hepatitis: a retrospective review of practice in the Netherlands
por: van den Brand, Floris F., et al.
Publicado: (2018)

Randomized Trial of Ciclosporin with 2-h Monitoring vs. Tacrolimus with Trough Monitoring in Liver Transplantation: DELTA Study
por: Ruijter, Bastian N., et al.
Publicado: (2023)

Profiling the patient with autoimmune hepatitis on calcineurin inhibitors: a real-world-experience
por: Pape, Simon, et al.
Publicado: (2020)

Population pharmacokinetics and genetics of oral meltdose tacrolimus (Envarsus) in stable adult liver transplant recipients
por: Martial, Lisa C., et al.
Publicado: (2021)

High discontinuation rate of azathioprine in autoimmune hepatitis, independent of time of treatment initiation
por: Pape, Simon, et al.
Publicado: (2020)

Tacrolimus 4‐hour monitoring in liver transplant patients is non‐inferior to trough monitoring: The randomized controlled FK04 trial
por: Ruijter, Bastian N., et al.
Publicado: (2022)

The Role of Calcium–Calcineurin–NFAT Signaling Pathway in Health and Autoimmune Diseases
por: Park, Yune-Jung, et al.
Publicado: (2020)

Calcineurin
por: Creamer, Trevor P.
Publicado: (2020)

Acute Liver Injury and Acute Liver Failure following Bariatric Surgery
por: van Golen, Rowan F., et al.
Publicado: (2022)

Refitting the Model for End‐Stage Liver Disease for the Eurotransplant Region
por: Goudsmit, Ben F. J., et al.
Publicado: (2021)

Joint modeling of liver transplant candidates outperforms the model for end‐stage liver disease: The effect of disease development over time on patient outcome
por: Goudsmit, Ben F. J., et al.
Publicado: (2021)

Survival benefit from liver transplantation for patients with and without hepatocellular carcinoma
por: Goudsmit, Ben F.J., et al.
Publicado: (2023)

Validation of the Model for End‐stage Liver Disease sodium (MELD‐Na) score in the Eurotransplant region
por: Goudsmit, Ben F. J., et al.
Publicado: (2020)

Invited response to “MELD calibration”
por: Goudsmit, Ben F. J., et al.
Publicado: (2020)

Development and validation of a dynamic survival prediction model for patients with acute-on-chronic liver failure
por: Goudsmit, Ben F.J., et al.
Publicado: (2021)

Characterization of calcineurin from Cryptococcus humicola and the application of calcineurin in aluminum tolerance
por: Zhang, Lei, et al.
Publicado: (2017)

Left atrial dysfunction is an independent predictor of mortality in patients with cirrhosis treated by transjugular intrahepatic portosystemic shunt
por: Meucci, Maria Chiara, et al.
Publicado: (2022)

Calcineurin in development and disease
por: Chen, Lei, et al.
Publicado: (2021)

BNP controls early load-dependent regulation of SERCA through calcineurin
por: Toischer, Karl, et al.
Publicado: (2010)

Calcineurin B in CD4(+) T Cells Prevents Autoimmune Colitis by Negatively Regulating the JAK/STAT Pathway
por: Mencarelli, Andrea, et al.
Publicado: (2018)

A Case of Autoimmune Hepatitis and Bisphosphonate-Related Osteonecrosis of the Jaw
por: de Boer, Y.S., et al.
Publicado: (2012)

Balanced interactions of calcineurin with AKAP79 regulate Ca(2+)–calcineurin–NFAT signaling
por: Li, Huiming, et al.
Publicado: (2012)

A polypeptide inhibitor of calcineurin blocks the calcineurin-NFAT signalling pathway in vivo and in vitro
por: Wang, Ping, et al.
Publicado: (2021)

Calcineurin and Systemic Lupus Erythematosus: The Rationale for Using Calcineurin Inhibitors in the Treatment of Lupus Nephritis
por: Rafael-Vidal, Carlos, et al.
Publicado: (2021)

Calcineurin/CXCR4 in T-ALL
por: Passaro, Diana, et al.
Publicado: (2015)

Calcineurin in a Crowded World
por: Cook, Erik C., et al.
Publicado: (2016)

Calcineurin, Synaptic Plasticity, and Memory
por: Weitlauf, Carl, et al.
Publicado: (2001)

Transient disorder: Calcineurin as an example
por: Creamer, Trevor P
Publicado: (2013)

Calcineurin Inhibitors and COVID-19
por: Hage, René, et al.
Publicado: (2022)

Calcineurin Inhibitors in Membranous Nephropathy
por: Ponticelli, Claudio, et al.
Publicado: (2021)

Calcineurin Inhibitors and COVID-19
por: Hage, René, et al.
Publicado: (2022)

Calcineurin regulation of cytoskeleton organization: a new paradigm to analyse the effects of calcineurin inhibitors on the kidney
por: Descazeaud, Virginie, et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_4m07eh8gpivou1kag5qmihc26c